Scott Dunseth Myers Dynavax Technologies Corp (DVAX) insider trading activity

Scott Dunseth Myers is of DYNAVAX TECHNOLOGIES CORP. Currently has a direct ownership of 25,446 shares of DVAX, which is worth approximately $316,039. The most recent transaction as insider was on May 23, 2024, when has been sold 5,357 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.4K

0% 3M change

26.67% 12M change

Total Value Held $316,039

Scott Dunseth Myers Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
May 23 2024	BUY Grant, award, or other acquisition	-	5,357 Added 17.39%	25,446 Common Stock
May 26 2023	BUY Grant, award, or other acquisition	-	5,357 Added 21.05%	20,089 Common Stock

Also insider at

AMAG

AMAG PHARMACEUTICALS, INC.

President & CEO

SELB

SELECTA BIOSCIENCES INC Healthcare

Director

HARP

Harpoon Therapeutics, Inc. Healthcare

VRDN

Viridian Therapeutics, Inc.\DE Healthcare

Chief Executive Officer

ZNTL

Zentalis Pharmaceuticals, Inc. Healthcare

Director

SDM